Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Linkage of genetic drivers and strain-specific germline variants confound mouse cancer genome analyses

ABSTRACT: Linkage of genetic drivers and strain-specific germline variants confound mouse cancer genome analyses

PROVIDER: PRJNA646626 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Linkage of genetic drivers and strain-specific germline variants confound mouse cancer genome analyses.

Project description: Not available

| S-EPMC7479137 | biostudies-literature

Linkage of genetic drivers and strain-specific germline variants confound mouse cancer genome analyses

Project description:Cell cultures were isolated from primary pancreatic cancers (PPTs) of KPC mice and subjected to array comparative genomic habridization (aCGH) for the investigation of copy nummber profiles. We generated primary pancreatic cancer cell cultures from KPC mice (n=4).

2020-07-17 | GSE154537 | GEO

Long-read nanopore sequencing of a pancreatic cancer cell culture derived from a KPC mouse.

Project description:Linkage of genetic drivers and strain-specific germline variants confound mouse cancer genome analyses

| PRJEB39427 | ENA

Whole exome sequencing of pancreatic cancer cell cultures derived from KPC mice (n=3).

Project description:Linkage of genetic drivers and strain-specific germline variants confound mouse cancer genome analyses

| PRJEB39429 | ENA

Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes.

Project description:Pediatric malignancies including Ewing sarcoma (EwS) feature a paucity of somatic alterations except for pathognomonic driver-mutations that cannot explain overt variations in clinical outcome. Here, we demonstrate in EwS how cooperation of dominant oncogenes and regulatory germline variants determine tumor growth, patient survival and drug response. Binding of the oncogenic EWSR1-FLI1 fusion transcription factor to a polymorphic enhancer-like DNA element controls expression of the transcription factor MYBL2 mediating these phenotypes. Whole-genome and RNA sequencing reveals that variability at this locus is inherited via the germline and is associated with variable inter-tumoral MYBL2 expression. High MYBL2 levels sensitize EwS cells for inhibition of its upstream activating kinase CDK2 in vitro and in vivo, suggesting MYBL2 as a putative biomarker for anti-CDK2-therapy. Collectively, we establish cooperation of somatic mutations and regulatory germline variants as a major determinant of tumor progression and highlight the importance of integrating the regulatory genome in precision medicine.

| S-EPMC6739408 | biostudies-literature

HINTS Data Linkage Project 2024

Project description:HINTS Data Linkage Project 2024

| PRJNA1302581 | ENA

HINTS Data Linkage Project 2022

Project description:HINTS Data Linkage Project 2022

| PRJNA1302582 | ENA

HINTS Data Linkage Project 2020

Project description:HINTS Data Linkage Project 2020

| PRJNA1302584 | ENA

HINTS Data Linkage Project 2020

Project description:HINTS Data Linkage Project 2020